pharmaceutical preparations namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoimm Read More

Classification Information

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, dyslipidemia, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification kind code

Mark Details

Serial Number

1889539

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 70 on 05^th Feb 2020	Opposed
Submitted for opposition 110 on 30^th Sep 2019	Proposed Opposition
Submitted for opposition 42 on 24^th Jul 2019	Advertised
Submitted for opposition 26 on 04^th Jul 2019	Approved
Submitted for opposition 27 on 17^th May 2019	Approval Notice Sent
Submitted for opposition 22 on 02^th Jan 2019	Search Recorded
Submitted for opposition 20 on 02^th Jan 2019	Examiner's First Report
Submitted for opposition 31 on 27^th Mar 2018	Formalized
Submitted for opposition 1 on 23^rd Mar 2018	Created
Submitted for opposition 30 on 22^nd Mar 2018	Filed